SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001420720-22-000073
Filing Date
2022-10-26
Accepted
2022-10-26 16:00:14
Documents
4
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20221208xdef14a.htm DEF 14A 871367
2 GRAPHIC tmb-20221208xdef14a004.jpg GRAPHIC 5883
3 GRAPHIC tmb-20221208xdef14a014.jpg GRAPHIC 148694
4 GRAPHIC tmb-20221208xdef14a013.jpg GRAPHIC 163331
  Complete submission text file 0001420720-22-000073.txt   1310804
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 221333237
SIC: 2834 Pharmaceutical Preparations